Skip to main content

Table 2 Biochemical parameters of participants

From: HDL functions and their interaction in patients with ST elevation myocardial infarction: a case control study

Parameters

Control (n = 110)

ACS baseline (n = 150)

ACS follow-up (n = 100)

Apo A-I (mg/ml)

142.1 ± 43.3

112.5 ± 27.3***

127.2 ± 36.6###

Apo B (mg/ml)

72.3 ± 22.4

83.9 ± 28.9***

62.7 ± 20.5###

Total cholesterol

(mg/dl)

161.2 ± 37.1

169.3 ± 42.0

137.0 ± 39.8###

HDL-C (mg/dl)

45.4 ± 9.6

40.2 ± 7.2***

38.3 ± 9.0

LDL-C (mg/dl)

104.0 ± 25.4

107.3 ± 34.9

80.8 ± 29.3###

VLDL-C (mg/dl)

16.9 ± 7.2

20.6 ± 11.2*

15.8 ± 11.1###

TG (mg/dl)

117.3 ± 45.2

126.8 ± 67.8

134.6 ± 90.2

  1. Data are expressed as mean ± standard deviation. ACS Acute coronary syndrome, Apo A-I Apolipoprotein A-I, Apo B Apolipoprotein B, HDL-C HDL-cholesterol, LDL-C LDL- cholesterol, VLDL-C Very Low Density lipoprotein-cholesterol, TG Triglycerides. *represents significance value for comparison between control and ACS patients. #represents significance value for comparison between ACS baseline and ACS follow-up patients. *p < 0.05; **p < 0.01; ***p < 0.001, #p < 0.05; ##p < 0.01; ###p < 0.001
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X